22 May 2013
Keywords: new, data, viracept, first-line, therapy, pfizer, protease
Article | 15 June 2001
New data for Pfizer's protease inhibitor Viracept (nelfinavir), whichreinforces the benefit of the drug as a first-line therapy for HIV
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 June 2001
14 June 2001
13 June 2001
© 2013 thepharmaletter.com